Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

NCT04336410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Infection

Interventions

DRUG: INO-4800
DEVICE: CELLECTRA® 2000

Sponsor

Inovio Pharmaceuticals

Collaborators

[object Object]